MEDIRAD

Implications of Medical Low Dose Radiation Exposure

CoordinatorUNIVERSITY OF NEWCASTLE UPON TYNE ; B-COM ; UNIVERSITE DE PARIS ; MEDIZINISCHE HOCHSCHULE BRANDENBURG CAMPUS GMBH ; INSTITUTO POLITECNICO DE COIMBRA ; Universitat Politècnica de Catalunya ; Associação para Investigação e Desenvolvimento da Faculdade de Medicina ; Philipp University of Marburg ; INSTITUT CLAUDIUS REGAUD ; THE ROYAL MARSDEN NATIONAL HEALTH SERVICE TRUST ; UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAET MAINZ ; UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN ; Ghent University ; VU University Medical Center ; Belgian Nuclear Research Centre ; KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN ; Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) ; Sapienza University of Rome ; INSTITUT CATALA D'ONCOLOGIA ; Inserm ; VASTRA GOTALANDS LANS LANDSTING ; Imperial College of Science Technology and Medicine ; EIBIR GEMEINNUTZIGE GMBH ZUR FORDERUNG DER ERFORSCHUNG DER BIOMEDIZINISCHEN BILDGEBUNG ; FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA ; UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT ; Otto-von-Guericke University Magdeburg ; Istituto Superiore di Sanità ; Paris Dauphine University ; University of Geneva ; Institut de Radioprotection et de Sûreté Nucléaire ; University of Bristol ; STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS ; ACADEMISCH ZIEKENHUIS GRONINGEN ; Nofer Institute of Occupational Medicine ; PANEPISTIMIO KRITIS ; Autonomous University of Barcelona
Grant period2017-06-01 - 2022-02-28
Funding bodyEuropean Union
Call numberNFRP-2016-2017-1
Grant number755523
IdentifierG:(EU-Grant)755523

Note: MEDIRAD aims to enhance the scientific bases and clinical practice of radiation protection (RP) in the medical field and thereby addresses the need to understand and evaluate the health effects of low dose ionising radiation exposure from diagnostic and therapeutic imaging and from off-target effects in radiotherapy (RT). MEDIRAD will pursue 3 major operational objectives: First, it will improve organ dose estimation and registration to inform clinical practice, optimise doses, set recommendations and provide adequate dosimetry for clinical-epidemiological studies of effects of medical radiation. Second, it aims to evaluate and understand the effects of medical exposures, focusing on the two major endpoints of public health relevance: cardiovascular effects of low to moderate doses of radiation from RT in breast cancer treatment incl. understanding of mechanisms; and long-term effects on cancer risk of low doses from CT in children. Third, it will develop science-based consensus policy recommendations for the effective protection of patients, workers and the general public. Within the 4-year project a multi-disciplinary consortium will, in close interaction with European medical associations, MELODI and EURADOS (1), develop a tool to determine image quality to maximise optimisation of RP in medical imaging, (2) improve and develop new individual organ/anatomical structure dosimetry from chest CT, I131 administration, fluoroscopy-guided procedures, hybrid imaging, and RT for breast cancer and interlinks with image quality measures, (3) conduct epidemiological studies of consequences of RT and CT, (4) identify potential novel imaging and circulating biomarkers and mechanisms of radiation effects, (5) develop innovative risk models, (6) develop and implement for the first time a European repository of patient dose and imaging data, (7) develop science-based recommendations, and (8) introduce novel approaches to bring together the nuclear and medical sectors.
     

Recent Publications

There are no publications


 Record created 2017-07-24, last modified 2023-02-14